Magnetic Iron Oxide Nanoparticles For Drug Delivery: Applications And Characteristics
Thomas Vangijzegem, Dimitri Stanicki, Sophie Laurent
Published 2019 · Medicine, Materials Science
Download PDFAnalyze on Scholarcy
ABSTRACT Introduction: For many years, the controlled delivery of therapeutic compounds has been a matter of great interest in the field of nanomedicine. Among the wide amount of drug nanocarriers, magnetic iron oxide nanoparticles (IONs) stand out from the crowd and constitute robust nanoplatforms since they can achieve high drug loading as well as targeting abilities stemming from their remarkable properties (magnetic and biological properties). These applications require precise design of the nanoparticles regarding several parameters which must be considered together in order to attain highest therapeutic efficacy. Areas covered: This short review presents recent developments in the field of cancer targeted drug delivery using magnetic nanocarriers as drug delivery systems. Expert opinion: The design of nanocarriers enabling efficient delivery of therapeutic compounds toward targeted locations is one of the major area of research in the targeted drug delivery field. By precisely shaping the structural properties of the iron oxide nanoparticles, drugs loaded onto the nanoparticles can be efficiently guided and selectively delivered toward targeted locations. With these goals in mind, special attention should be given to the pharmacokinetics and in vivo behavior of the developed nanocarriers.
This paper references
PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer.
Prashanth K B Nagesh (2016)
Metal ferrite nanoparticles: Synthesis, characterization, and studies on decontamination of sulfur mustard
J. Praveen Kumar (2017)
Tumor Cells Enhance Their Own CD44 Cleavage and Motility by Generating Hyaluronan Fragments*
Kazuki N. Sugahara (2006)
Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.
Ajay Kumar Gupta (2007)
Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro.
Forrest M Kievit (2011)
Stimuli-responsive nanocarriers for drug delivery.
Simona Mura (2013)
N Dubrawsky (1989)
Remote magnetic targeting of iron oxide nanoparticles for cardiovascular diagnosis and therapeutic drug delivery: where are we now?
Michael Bietenbeck (2016)
Clinical applications of magnetic nanoparticles
Thanh NTK (2018)
Cancer statistics, 2016
Rebecca L. Siegel Mph (2016)
Iron Oxide Nanoparticles for Magnetically-Guided and Magnetically-Responsive Drug Delivery
Joan Ramis Estelrich (2015)
Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies.
Karel Ulbrich (2016)
Magnetic nanoparticles: synthesis, functionalization, and applications in bioimaging and magnetic energy storage.
Natalie A. Frey (2009)
Cisplatin-incorporated hyaluronic acid nanoparticles based on ion-complex formation.
Young-Il Jeong (2008)
Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine*
George Mattheolabakis (2015)
pH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents.
Mahdi Karimi (2016)
Magnetic Nanoparticles: Surface Effects and Properties Related to Biomedicine Applications
Bashar Issa (2013)
Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications
Wei Wu (2015)
The President and Society for Analytical Chemistry Gold Medallist
Young-wook Jun (1973)
Chitosan—A versatile semi-synthetic polymer in biomedical applications
Mamoni Dash (2011)
Superparamagnetic iron oxide nanoparticles conjugatedwith folic acid for dual target-specific drug delivery and MRI in cancer
Y Huang (2017)
Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin
Sarah D. Brown (2010)
Artemisinin loaded chitosan magnetic nanoparticles for the efficient targeting to the breast cancer.
Subramanian Natesan (2017)
Use of RNAi technology to develop a PRSV-resistant transgenic papaya
R. Jia (2017)
Hybrid phase-locked loop with fast locking time and low spur in a 0.18-um CMOS process
Siheng Zhu (2014)
Antitumor Activity of Artemisinin and Its Derivatives: From a Well-Known Antimalarial Agent to a Potential Anticancer Drug
María del Pilar Crespo-Ortiz (2012)
Protein corona: a new approach for nanomedicine design
Văn Hồng Nguyên (2017)
A simple approach to design chitosan functionalized Fe3O4 nanoparticles for pH responsive delivery of doxorubicin for cancer therapy
Mahesh G Adimoolam (2018)
Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer
Nirmala Chandralega Kampan (2015)
Functionalized nanoparticles with long-term stability in biological media.
Chen Fang (2009)
Protein corona and nanoparticles: how can we investigate on?
Francesca Pederzoli (2017)
Cisplatin-tethered gold nanoparticles that exhibit enhanced reproducibility, drug loading, and stability: a step closer to pharmaceutical approval?
Gemma E. Craig (2012)
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.
Omid Veiseh (2010)
This review provides relevant information concerning major aspects of the protein corona formation, characterization and consequences on the biological properties of nanomaterials
Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications
P Reimer (2003)
Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
Gozde Unsoy (2014)
Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges
Sophie Laurent (2014)
Pharmaceutical formulation of HSA hybrid coated iron oxide nanoparticles for magnetic drug targeting.
Jan Zaloga (2016)
The development of stable aqueous suspensions of PEGylated SPIONs for biomedical applications.
Kerdiles Herve (2008)
Multifunctionalization of magnetic nanoparticles for controlled drug release: a general approach.
Alfonso Latorre (2014)
A new approach to follow the formation of iron oxide nanoparticles synthesized by thermal decomposition.
Sarah Belaïd (2013)
Cancer theranostics: the rise of targeted nanoparticles
AJ Cole (2011)
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Michiru Nishita (2016)
Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer.
Lucas de Sousa Cavalcante (2014)
Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes
Liqun Zhao (2017)
Chitosan magnetic nanoparticles for pH responsive Bortezomib release in cancer therapy.
Gozde Unsoy (2014)
Magnetic inductive heating of organs of mouse models treated by copolymer coated Fe 3 O 4 nanoparticles
Hồng Nam Phạm (2017)
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging.
Suphiya Parveen (2012)
Ultra-large-scale production of ultrasmall superparamagnetic iron oxide nanoparticles for T1-weighted MRI
Yuanpeng Rui (2016)
Biocompatibility of Chitosan Carriers with Application in Drug Delivery
Susana Cruz Rodrigues (2012)
Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers
Pilar Abad Calvo (1997)
Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.
Emilie Munnier (2008)
Multifunctionalized iron oxide nanoparticles for selective targeting of pancreatic cancer cells.
Sara Maria Trabulo (2017)
A RNA-DNA Hybrid Aptamer for Nanoparticle-Based Prostate Tumor Targeted Drug Delivery
J. H. C. Leach (2016)
Targeting multidrug resistance in cancer
Gergely Szakács (2006)
Magnetic Properties of Polyvinyl Alcohol and Doxorubicine Loaded Iron Oxide Nanoparticles for Anticancer Drug Delivery Applications
Muhammad Nadeem (2016)
Heterostructured magnetic nanoparticles: their versatility and high performance capabilities.
Young-wook Jun (2007)
PET/NIRF/MRI triple functional iron oxide nanoparticles.
Jin Xie (2010)
Human serum albumin coated iron oxide nanoparticles for efficient cell labelling
J Xie (2010)
Clinical Applications of Magnetic Nanoparticles : From Fabrication to Clinical Applications
Nguyen Tk Thanh (2018)
Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging.
Elena Taboada (2007)
Human serum albumin coated iron oxide nanoparticles for efficient cell labeling.
Jin Y. Xie (2010)
Magnetic iron oxide nanoparticles: Synthesis and surface coating techniques for biomedical applications
Sun Sheng-nan (2014)
Synthesis, properties, and applications of magnetic iron oxide nanoparticles
Amyn S. Teja (2009)
Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications
Ruirui Qiao (2009)
EPR: Evidence and fallacy.
Joseph W. Nichols (2014)
Development and characterization of magnetic iron oxide nanoparticles with a cisplatin-bearing polymer coating for targeted drug delivery
Harald Unterweger (2014)
Poly-paclitaxel/cyclodextrin-SPION nano-assembly for magnetically guided drug delivery system.
Hyeon-Jeong Jeon (2016)
Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer
Md Shakir Uddin Ahmed (2017)
Synthesis of Fe Oxide Core/Au Shell Nanoparticles by Iterative Hydroxylamine Seeding
Jennifer L. Lyon (2004)
A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting.
Jean Pierre Gautier (2012)
Water purification using magnetic assistance: a review.
Ritu D. Ambashta (2010)
Application of a superparamagnetic iron oxide (Resovist) for MR imaging of human cerebral blood volume.
Peter Reimer (1995)
Coronary MR angiography using citrate-coated very small superparamagnetic iron oxide particles as blood-pool contrast agent: initial experience in humans.
Moritz Wagner (2011)
VSION as high field MRI T1 contrast agent: evidence of their potential as positive contrast agent for magnetic resonance angiography.
Thomas Vangijzegem (2018)
Nanotechnological carriers for cancer chemotherapy: the state of the art.
Marilene Estanqueiro (2015)
Preparation of aqueous magnetic liquids in alkaline and acidic media
Rene. Massart (1981)
Properties of magnetite nanoparticles synthesized through a novel chemical route
Deepa Thapa (2004)
Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.
Gee Young Lee (2013)
Magnetic iron oxide nanoparticles: synthesis and applications
Chengyin Fu (2012)
Multifunctionalized iron oxide nanoparticles for selective drug delivery to CD44-positive cancer cells.
Antonio Aires (2016)
Hypersensitivity reactions from taxol.
Raymond B. Weiss (1990)
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
Ajay Kumar Gupta (2005)
Doxorubicin pathways: pharmacodynamics and adverse effects
Caroline F. Thorn (2011)
Carboxy-silane coated iron oxide nanoparticles: a convenient platform for cellular and small animal imaging.
Dimitri Stanicki (2014)
Doxorubicin-Conjugated Heparin-Coated Superparamagnetic Iron Oxide Nanoparticles for Combined Anticancer Drug Delivery and Magnetic Resonance Imaging.
Yi Yang (2016)
Mode of action of docetaxel - a basis for combination with novel anticancer agents.
Roy S. Herbst (2003)
Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.
Morteza Mahmoudi (2011)
Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy.
Robert C. Kane (2003)
Doxorubicin-loaded mesoporous magnetic nanoparticles to induce apoptosis in breast cancer cells.
Yan Yan Zou (2015)
Current development in the formulations of non‐injection administration of paclitaxel
Xiyou Du (2018)
• The authors developed magnetic nanocarriers carrying doxorubicin through an original approach using a pre-formed DOX-Fe 2+ complex in a simple protocol
Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.
Byung Hyo Kim (2011)
Doxil®--the first FDA-approved nano-drug: lessons learned.
Yechezkel Chezy Barenholz (2012)
Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Yinping Huang (2017)
Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer
Y Huang (2017)
Anti-HER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells.
Qingxin Mu (2015)
Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery.
Challa S. S. R. Kumar (2011)
HSA coated iron oxide nanoparticles as drug delivery vehicles for cancer therapy.
Qimeng Quan (2011)
Cancer theranostics: the rise of targeted magnetic nanoparticles.
Adam J. Cole (2011)
Synthesis and Characterization of Iron Oxide Nanoparticles and Applications in the Removal of Heavy Metals from Industrial Wastewater
Zuolian Cheng (2012)
Cisplatin in cancer therapy: molecular mechanisms of action.
Shaloam R. Dasari (2014)
Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma.
Daniel Cantero (1997)
Cancer statistics, 2016.
Rebecca L Siegel (2016)
Influence of experimental parameters on iron oxide nanoparticles properties synthesized by thermal decomposition: size and nuclear magnetic resonance studies.
Sarah Belaid (2018)
Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility
Jan Zaloga (2014)
Chemical synthesis and assembly of uniformly sized iron oxide nanoparticles for medical applications.
Daishun Ling (2015)
An MRI-based classification scheme to predict passive access of 5 to 50-nm large nanoparticles to tumors
Anastassia Karageorgis (2016)
Chitosan exerts anticancer activity through induction of apoptosis and cell cycle arrest in oral cancer cells.
Yuniardini S Wimardhani (2014)
Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.
D. I. Chen (2011)
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.
Sophie Laurent (2008)
Multifunctional superparamagnetic iron oxide nanoparticles for combined chemotherapy and hyperthermia cancer treatment.
Christopher A Quinto (2015)
Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications
Peter Reimer (2002)
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Edgar Pérez-Herrero (2015)
Tailored functionalization of iron oxide nanoparticles for MRI, drug delivery, magnetic separation and immobilization of biosubstances.
Kateřina Holá (2015)
Artemisinin and Its Synthetic Derivatives as a Possible Therapy for Cancer
Enrique Konstat-Korzenny (2018)
A review of current coupling agents for modification of metal oxide nanoparticles
Shadpour E. Mallakpour (2015)
Superparamagnetic MFe2O4 (M = Fe, Co, Mn) Nanoparticles: Tuning the Particle Size and Magnetic Properties through a Novel One-Step Coprecipitation Route
Clara Pereira (2012)
Cisplatin drug delivery using gold-coated iron oxide nanoparticles for enhanced tumour targeting with external magnetic fields
Amelia J. Wagstaff (2012)
Synthesis optimization and characterization of chitosan-coated iron oxide nanoparticles produced for biomedical applications
Gozde Unsoy (2012)
This paper is referenced by
Methotrexate-conjugated chitosan-grafted pH- and thermo-responsive magnetic nanoparticles for targeted therapy of ovarian cancer.
Marziyeh Fathi (2019)
Magnetic Nanoparticles: A Unique Gene Delivery System in Plant Science
Mohamed A. Mohamed (2019)
Influence of Experimental Parameters of a Continuous Flow Process on the Properties of Very Small Iron Oxide Nanoparticles (VSION) Designed for T1-Weighted Magnetic Resonance Imaging (MRI)
Thomas Vangijzegem (2020)
Magnetic Nanoparticle Systems for Nanomedicine—A Materials Science Perspective
V Socoliuc (2020)
ZnO/CNT@Fe3O4 induces ROS-mediated apoptosis in chronic myeloid leukemia (CML) cells: an emerging prospective for nanoparticles in leukemia treatment.
Amir-Mohammad Yousefi (2020)
Magnetic nanoparticles (MNPs) a promising drug delivery of anticancer agents: A review
Sharda Shinde (2020)
Metronidazole-functionalized iron oxide nanoparticles for molecular detection of hypoxic tissues.
Miriam Filippi (2019)
Sight and switch off: Nerve density visualization for interventions targeting nerves in prostate cancer
Huijuan You (2020)
Nobiletin and Derivatives: Functional Compounds from Citrus Fruit Peel for Colon Cancer Chemoprevention
Joanna Xuan Hui Goh (2019)
Nanocarriers as Magic Bullets in the Treatment of Leukemia
Mohammad Houshmand (2020)
A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model
Alexander P Klapproth (2020)
A multiparametric model for the industrialization of co-precipitation synthesis of nano-commodities.
Lilian C Alarcon Segovia (2020)
In situ preparation of non-viral gene vectors with folate/magnetism dual targeting by hyperbranched polymers
Yunfeng Shi (2020)
Recent developments in the use of organic-inorganic nanohybrids for drug delivery.
Danushika C. Manatunga (2019)
Functionalized Iron Oxide Nanoparticles Conjugate of Multi-Anchored Schiff’s Base Inorganic Heterocyclic Pendant Groups: Cytotoxicity Studies
Dinesh Kumar Chelike (2020)
Direct synthesis of 3D flower-like maghemite particles and their properties
Bao-yan Zhang (2020)
Magnetic nanocarriers: Emerging tool for the effective targeted treatment of lung cancer
Janani Sadhasivam (2020)
Augmented interaction of multivalent arginine coated gold nanoclusters with lipid membranes and cells
Estelle Porret (2020)
Synthesis, Properties and Applications of Magnetic Nanoparticles and Nanowires—A Brief Introduction
Evgeny Katz (2019)
Cerium- and Iron-Oxide-Based Nanozymes in Tissue Engineering and Regenerative Medicine
Michelle M. T. Jansman (2019)
The clearance and biodistribution of magnetic composite nanoparticles in healthy and osteoarthritic rat knees.
Brittany D Partain (2020)
Green Nanoparticles for Biomedical and Bioengineering Applications
Luciano Prado da Silva (2020)
Nanoparticles and their Biomedical Applications
Ajit Kumar N. Shukla (2020)
Synthesis of micelles based on chitosan functionalized with gold nanorods as a light sensitive drug delivery vehicle.
Ali Pourjavadi (2020)
Chitosan-coated magnetic solid lipid nanoparticles for controlled release of letrozole
Zeynab Ahmadifard (2020)
Magnetic Bio-Derivatives: Preparation and Their Uses in Biotechnology
Mariana Paola Cabrera (2019)
Fabrication and Evaluation of Anti-Cancer Efficacy of Lactoferrin-Coated Maghemite and Magnetite Nanoparticles.
Majid Sharifi (2019)
Nonharmonic Driving Fields for Enhancement of Nanoparticle Heating Efficiency in Magnetic Hyperthermia
Paolo Allia (2019)
Chemotherapeutic potential of L-carnosine from stimuli-responsive magnetic nanoparticles against breast cancer model.
Ragwa Mohamed Farid (2020)